Baxter Receives 510(k) Clearance From FDA for V-Link With VitalShield, New Antimicrobial Intravascular Technology

Drug Week via NewsEdge Corporation :

2007 NOV 30 - (NewsRx.com) -- Baxter Healthcare Corporation announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its V-Link Luer-activated device (LAD) with VitalShield protective coating. V-Link with VitalShield is the first needleless IV connector containing an antimicrobial coating. This new device has been shown to kill 99.9 percent of specific common pathogens (infection- causing microorganisms) known to cause catheter-related blood stream infections, including the highly treatment-resistant bacteria called methicillin-resistant Staphylococcus aureus, or MRSA. The Centers for Disease Control and Prevention (CDC) recently reported that MRSA infections cause an estimated 18,650 deaths per year in the United States (U.S.), which is more deaths in the U.S. per year than HIV/AIDS (see also Drug Resistance).

read the full article: http://www.devicelink.com/newsedge/